Magazine Article | July 1, 2021

How A First-Time CEO Transformed Retrophin Into Travere Therapeutics

Source: Life Science Leader

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

“ARE YOU KIDDING ME?”

That was the first thought Eric Dube, Ph.D., had when an executive recruiter pitched to him a CEO opportunity at Retrophin back in 2018. After all, Dube knew of the San Diego-based biopharma’s infamous past with its cofounder and one-time CEO, Martin Shkreli, so his initial reaction was to be dubious.

access the Magazine Article!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Life Science Leader? Subscribe today.

Subscribe to Life Science Leader X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Life Science Leader

Please tell us more about you so that we can customize our newsletters to your specific interests: